L-NAME- and ADMA-induced sympathetic neural activation in conscious rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 290, Issue 3, 2006, Pages

  Augustyniak, Robert A ^a,d   Victor, Ronald G ^a   Morgan, Donald A ^b   Zhang, Weiguo ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c BOSTON SCIENTIFIC CORPORATION   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asymmetric dimethylarginine; Baroreceptor reflex; Neurogenic hypertension; Sino aortic denervation; Sympathetic nervous system

Indexed keywords

N(G) NITROARGININE METHYL ESTER; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE; ARGININE; DRUG DERIVATIVE; N,N DIMETHYLARGININE; N,N-DIMETHYLARGININE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; MEAN ARTERIAL PRESSURE; NERVE CELL; NERVE EXCITABILITY; NONHUMAN; PRESSORECEPTOR; PRIORITY JOURNAL; RAT; SYMPATHETIC NERVE; ADRENERGIC SYSTEM; ANIMAL; CONSCIOUSNESS; DRUG EFFECT; INNERVATION; KIDNEY; METABOLISM; PHYSIOLOGY; PRESSORECEPTOR REFLEX; SINUS NODE; SPRAGUE DAWLEY RAT; SYMPATHECTOMY;

ANIMALS; ARGININE; BAROREFLEX; CONSCIOUSNESS; FEMALE; KIDNEY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; SINOATRIAL NODE; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM;

EID: 33645407190     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00768.2004     Document Type: Article

References (54)

1. Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, and Vallance P. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23: 1455-1459, 2003.
2. Augustyniak RA, Thomas GD, Victor RG, and Zhang W. Nitric oxide pathway as new drug targets for refractory hypertension. Curr Pharm Des 11: 3307-3315, 2005.
3. Baylis C and Vallance P. Nitric oxide and blood pressure: effects of nitric oxide deficiency. Curr Opin Nephrol Hypertens 5: 80-88, 1996.
4. Cunha RS, Cabral AM, and Vasquez EC. Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats. Am J Hypertens 6: 806-809, 1993.
5. Curgunlu A, Uzun H, Bavunoglu I, Karter Y, Genc H, and Vehid S. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension. J Hum Hypertens 19: 629-633, 2005.
6. Furchgott RF and Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
7. Habler HJ, Wasner G, Bartsch T, and Janig W. Responses of rat postganglionic sympathetic vasoconstrictor neurons following blockade of nitric oxide synthesis in vivo. Neuroscience 77: 899-909, 1997.
8. Hakim MA, Hirooka Y, Coleman MJ, Bennett MR, and Dampney RA. Evidence for a critical role of nitric oxide in the tonic excitation of rabbit renal sympathetic preganglionic neurones. J Physiol 482: 401-407, 1995.
9. Harada S, Tokunaga S, Momohara M, Masaki H, Tagawa T, Imaizumi T, and Takeshita A. Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ Res 72: 511-516, 1993.
10. Hirai T, Musch TI, Morgan DA, Kregel KC, Claassen DE, Pickar JG, Lewis SJ, and Kenney MJ. Differential sympathetic nerve responses to nitric oxide synthase inhibition in anesthetized rats. Am J Physiol Regul Integr Comp Physiol 269: R807-R813, 1995.
11. Imaizumi T, Brunk SD, Gupta BN, and Thames MD. Central effect of intravenous phenylephrine on baroreflex control of renal nerves. Hypertension 6: 906-914, 1984.
12. Ito S and Sved AF. Influence of GABA in the nucleus of the solitary tract on blood pressure in baroreceptor-denervated rats. Am J Physiol Regul Integr Comp Physiol 273: R1657-R1662, 1997.
13. Jin JS and D'Alecy LG. Central and peripheral effects of asymmetric dimethylarginine, an endogenous nitric oxide synthetase inhibitor. J Cardiovasc Pharmacol 28: 439-446, 1996.
14. John S and Schmieder RE. Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences. J Hypertens 18: 363-374, 2000.
15. Kelm M. The L-arginine-nitric oxide pathway in hypertension. Curr Hypertens Rep 5: 80-86, 2003.
16. Krieger EM. Neurogenic hypertension in the rat. Circ Res 15: 511-521, 1964.
17. Kumagai H, Averill DB, Khosla MC, and Ferrario CM. Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats. Hypertension 21: 476-484, 1993.
18. Lacolley P, Bezie Y, Girerd X, Challande P, Benetos A, Boutouyrie P, Ghodsi N, Lucet B, Azoui R, and Laurent S. Aortic distensibility and structural changes in sinoaortic-denervated rats. Hypertension 26: 337-340, 1995.
19. Liu JL, Murakami H, and Zucker IH. Angiotensin II-nitric oxide interaction on sympathetic outflow in conscious rabbits. Circ Res 82: 496-502, 1998.
20. Liu JL, Murakami H, and Zucker IH. Effects of NO on baroreflex control of heart rate and renal nerve activity in conscious rabbits. Am J Physiol Regul Integr Comp Physiol 270: R1361-R1370, 1996.
21. Lumme A, Vanhatalo S, and Soinila S. Axonal transport of nitric oxide synthase in autonomic nerves. J Auton Nerv Syst 56: 207-214, 1996.
22. Mallamaci F, Tripepi G, Maas R, Malatino L, Boger R, and Zoccali C. Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease. J Am Soc Nephrol 15: 435-441, 2004.
23. Manthey J, Dietz R, Opherk D, Osterziel KJ, Leinberger H, and Kubler W. Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness. Am J Cardiol 70: 224-228, 1992.
24. McKeogh DF, O'Donaughy TL, and Brooks VL. NO and endogenous angiotensin II interact in the generation of renal sympathetic nerve activity in conscious rats. Am J Physiol Heart Circ Physiol 286: H1258-H1265, 2004.
25. Nakamura T and Hayashida Y. Autonomic cardiovascular responses to smoke exposure in conscious rats. Am J Physiol Regul Integr Comp Physiol 262: R738-R745, 1992.
26. Okamoto H, Hoka S, Kawasaki T, Okuyama T, and Takahashi S. L-arginine attenuates ketamine-induced increase in renal sympathetic nerve activity. Anesthesiology 81: 137-146, 1994.
27. Rees DD, Palmer RM, Schulz R, Hodson HF, and Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101: 746-752, 1990.
28. Rodrigo J, Springall DR, Uttenthal O, Bentura ML, Abadia-Molina F, Riveros-Moreno V, Martinez-Murillo R, Polak JM, and Moncada S. Localization of nitric oxide synthase in the adult rat brain. Philos Trans R Soc Lond B Biol Sci 345: 175-221, 1994.
29. G-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone? Circ Res 70: 607-611, 1992.
30. Sander M, Chavoshan B, and Victor RG. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 33: 937-942, 1999.
31. Sander M, Hansen J, and Victor RG. The sympathetic nervous system is involved in the maintenance but not initiation of the hypertension induced by N(ω)-nitro-L-arginine methyl ester. Hypertension 30: 64-70, 1997.
32. Sander M, Hansen PG, and Victor RG. Sympathetically mediated hypertension caused by chronic inhibition of nitric oxide. Hypertension 26: 691-695, 1995.
33. Sander M and Victor RG. Neural mechanisms in nitric-oxide-deficient hypertension. Curr Opin Nephrol Hypertens 8: 61-73, 1999.
34. Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, and Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361: 1511-1517, 2003.
35. Schlaich MP, Parnell MM, Ahlers BA, Finch S, Marshall T, Zhang WZ, and Kaye DM. Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects. Circulation 110: 3680-3686, 2004.
36. Schreihofer AM and Sved AF. Use of sinoaortic denervation to study the role of baroreceptors in cardiovascular regulation. Am J Physiol Regul Integr Comp Physiol 266: R1705-R1710, 1994.
37. Scrogin KE, Hatton DC, Chi Y, and Luft FC. Chronic nitric oxide inhibition with L-NAME: effects on autonomic control of the cardiovascular system. Am J Physiol Regul Integr Comp Physiol 274: R367-R374, 1998.
38. Soinila S, Vanhatalo S, Lumme A, Back N, and Soinila J. Nitric oxide synthase in the autonomic and sensory ganglia innervating the submandibular salivary gland. Microsc Res Tech 35: 32-43, 1996.
39. Terenghi G, Riveros-Moreno V, Hudson LD, Ibrahim NB, and Polak JM. Immunohistochemistry of nitric oxide synthase demonstrates immunoreactive neurons in spinal cord and dorsal root ganglia of man and rat. J Neurol Sci 118: 34-37, 1993.
40. Thomas GD, Zhang W, and Victor RG. Nitric oxide deficiency as a cause of clinical hypertension: promising new drug targets for refractory hypertension. JAMA 285: 2055-2057, 2001.
41. Togashi H, Sakuma I, Yoshioka M, Kobayashi T, Yasuda H, Kitabatake A, Saito H, Gross SS, and Levi R. A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther 262: 343-347, 1992.
42. Tran CT, Leiper JM, and Vallance P. The DDAH/ADMA/NOS pathway. Atheroscler Suppl 4: 33-40, 2003.
43. Traystman RJ, Moore LE, Helfaer MA, Davis S, Banasiak K, Williams M, and Hurn PD. Nitro-L-arginine analogues. Dose- and time-related nitric oxide synthase inhibition in brain. Stroke 26: 864-869, 1995.
44. Vallance P, Leone A, Calver A, Collier J, and Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575, 1992.
45. Vincent SR and Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46: 755-784, 1992.
46. Yamada SS, Sassaki AL, Fujihara CK, Malheiros DM, De Nucci G, and Zatz R. Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade. Hypertension 27: 1165-1172, 1996.
47. Zanchi A, Schaad NC, Osterheld MC, Grouzmann E, Nussberger J, Brunner HR, and Waeber B. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system. Am J Physiol Heart Circ Physiol 268: H2267-H2273, 1995.
48. Zanzinger J, Czachurski J, and Seller H. Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide. Am J Physiol Regul Integr Comp Physiol 268: R958-R962, 1995.
49. Zanzinger J, Czachurski J, and Seller H. Neuronal nitric oxide reduces sympathetic excitability by modulation of central glutamate effects in pigs. Circ Res 80: 565-571, 1997.
50. Zhang K, Mayhan WG, and Patel KP. Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity. Am J Physiol Regul Integr Comp Physiol 273: R864-R872, 1997.
51. Zhang W, Pettersson A, Thoren P, and Hedner T. Effects of 1,1-dimethylguanidine administration on blood pressure, heart rate and renal sympathetic nerve activity in normotensive and spontaneously hypertensive rats. Acta Physiol Scand 159: 1-6, 1997.
52. Zhang W, Sun X, Zhao X, Thoren P, and Hedner T. Effects of hydralazine on renal sympathetic nerve activity in normal and congestive heart failure rats. Acta Physiol Scand 161: 7-14, 1997.
53. Zhang W and Thoren P. Using Bisico S4i for electrodes and peripheral nerve embedding. J Pharmacol Toxicol Methods 37: 117-118, 1997.
54. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, and Boger R. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358: 2113-2117, 2001.